Read + Share
Kislova M, Dmitrieva E, Naumova E, Pochtar M, et al. Minimal residual disease-guided ibrutinib and venetoclax in patients with chronic
lymphocytic leukaemia and complex karyotype. Br J Haematol 2026;209:1664-1672.
PMID: 42618050
|
 |
|
Kislova M, Dmitrieva E, Naumova E, Pochtar M, et al. Minimal residual disease-guided ibrutinib and venetoclax in patients with chronic
lymphocytic leukaemia and complex karyotype. Br J Haematol 2026;209:1664-1672.
PMID: 42618050
|
|
|
|